New Data on Long-Acting Investigational Medication for HIV Prevention

Scientist holds vial of experimental HIV prevention medicine

We’ve announced topline results from an interim analysis of a clinical trial of our investigational medication for HIV prevention. This is the second Phase 3 trial to demonstrate the efficacy and safety profile for this medication. The first trial, PURPOSE 1 — which studied HIV prevention among cisgender women in sub-Saharan Africa — was unblinded early because it met key efficacy endpoints.

Our Purpose

A group of people sitting at a table

We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.

Our Mission

Recent Stories

Eyepiece of a microscope

Join Our Team

We're Hiring